Table 13. Effect of GBTSs on Proliferation Rates of Splenocyte in Vitro
Concentration (mg/㎖) | Proliferation rates (%) |
GBT (mg/㎖) | GBTG (mg/㎖) | GBTJ (mg/㎖) |
con(-) | 100.0±5.23 | 100.0±5.10 | 100.0±4.64 |
con(+) | 104.1±5.96 | 102.2±11.13 | 111.6±6.42 |
0.01 | 109.6±4.32 | 105.5±8.75 | 117.1±6.34 |
0.02 | 113.1±4.81 | 108.7±8.12 | 118.5±8.48 |
0.03 | 112.1±9.47 | 115.2±7.10 | 126.1±13.31 |
0.06 | 113.1±10.25** | 107.5±7.11 | 128.0±12.26* |
0.13 | 120.6±7.28** | 108.2±7.43 | 127.0±5.96 |
0.25 | 120.2±8.82** | 111.2±12.87 | 128.1±18.62* |
0.50 | 124.7±6.10** | 115.7±10.18* | 127.8±7.58* |
1.00 | 127.8±5.88** | 128.1±4.74** | 128.7±5.31* |
Con(-): GBTSs and LPS not treated group, Con(+): GBTSs not treated and LPS treated group, GBT: BTS except talcum, GBTG: GBT added Lonicerae Japonicae Flos, GPTJ: GBT added Kochiae Fructus. Values are represented as mean±SD. *: Indicates significant difference from control(+) group(*P<0.05). **: Indicates significant difference from control(+) group(**P<0.01).